News

2015 Apr 30

Lis elected to American Academy of Arts and Sciences

Meyer Cancer Center member John Lis, the Barbara McClintock Professor of Molecular Biology and Genetics based in Ithaca, was among three Cornell faculty members recently elected to the American Academy of Arts and Sciences. Read more

2015 Apr 29

Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities

Research by David Lyden into the immune suppression function of the Inhibitor of Differentiation 1 gene may lead to new therapies for melanoma and other advanced-stage cancers. Read more

2015 Apr 29

Esophageal cancer: What happens after 5 years?

Esophageal cancer patients who survived five years after surgery were likely to survive longer despite recurrence risk, according to a new study by Brendon Stiles, M.D. Read more

2015 Apr 28

Precision Medicine: Working Toward Custom-Fitted Cures

Mark Rubin speaks to U.S. News and World Reports about the future of precision medicine Read more

2015 Apr 27

The brain tumor is benign, but threats remain

Susan Pannullo talks to the New York Times about the importance of detecting brain tumors when they are small. Read more

2015 Apr 23

Cornell "cosmeceutical" cancer prevention cream inspires start-up

CUL4A Ubiquitin Ligase inhibitors technology created by pathology professor Pengbo Zhou is making its way to market. Read more

2015 Apr 23

Tumor cells prefer easy way out

Cynthia Reinhart-King study illuminates the mechanics of tumor cell migration. Read more

2015 Apr 23

Clinical experience in gastric cancer and present positioning of anti-angiogenesis drugs

Manish Shah, M.D., speaks about the use of anti-angiogenesis drugs in gastric cancer at an event in Milan, Italy. Read more

2015 Apr 22

Another kudos for Cantley

Meyer director Lewis Cantley has been named the recipient of the 3rd annual Ross Prize in Molecular Medicine. Read more

2015 Apr 21

New tool predicts drug targets and IDs new anticancer compounds

A new computational tool mines millions of data points to shed light on the targets and actions of certain molecules Read more

2015 Apr 20

Changes in cancer epigenome implicated in chemotherapy resistance and lymphoma relapse

A study in Nature Communications by Olivier Elemento and colleagues suggests that global changes in cancer cells' epigenome may be a powerful force in determining disease progression Read more

2015 Apr 20

How patients can benefit from clinical trials

John Leonard talks about the benefit of participating in clinical trials at reputable research institutions. Read more

2015 Apr 19

New study shows aspirin use can cut the risk of some kinds of cancer

Heather Yeo speaks to CBS Evening News about new aspirin study. Read more

2015 Apr 16

Immunotherapy research in pancreatic cancer given $1m boost

Douglas Fearon has received a grant to support his research into eliminating T cell barriers in pancreatic cancer patients. Read more

2015 Apr 15

New genomic research amends earlier triple negative breast cancer finding

A paper in Nature from Mark Rubin, Sandra Shin and Juan Miguel Mosquera underscores the importance of independent study validation and careful assay development. Read more

2015 Apr 15

Big Data Key to Precision Medicine's Success

Mark A. Rubin, director of the Institute for Precision Medicine, writes in Nature about the practicalities of realizing the potential of precision medicine. Read more

2015 Apr 14

Researchers Sequence Genome of Anaplastic Large Cell Lymphoma

A team of researchers led by Giorgio Inghirami has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. Read more

2015 Apr 13

Researcher's resolve leads to breakthrough drug

Selina Chen-Kiang's investigations into the cell cycle helped lead to the successful launch of CDK4/6 inhibitor palbociclib (IBRANCE). Read more

2015 Apr 12

Can cancer be stopped?

Harold Varmus, M.D., pens a guest piece in the New York Daily News about the remarkable progress made in cancer research and the daunting road ahead. Read more

Photo of Dr. Dattatreyudu Nori getting a Padma Shri award from Indian President Pranab Mukherkee

2015 Apr 09

Dattatreyudu Nori awarded one of India's highest civil honors

Dattatreyudu Nori, M.D., professor of clinical radiation oncology, has been awarded the Padma Shri, one of India's highest civil awards. Read more

News

Lis elected to American Academy of Arts and Sciences

Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities

Esophageal cancer: What happens after 5 years?

Precision Medicine: Working Toward Custom-Fitted Cures

The brain tumor is benign, but threats remain

Cornell "cosmeceutical" cancer prevention cream inspires start-up

Tumor cells prefer easy way out

Clinical experience in gastric cancer and present positioning of anti-angiogenesis drugs

Another kudos for Cantley

New tool predicts drug targets and IDs new anticancer compounds

Changes in cancer epigenome implicated in chemotherapy resistance and lymphoma relapse

How patients can benefit from clinical trials

New study shows aspirin use can cut the risk of some kinds of cancer

Immunotherapy research in pancreatic cancer given $1m boost

New genomic research amends earlier triple negative breast cancer finding

Big Data Key to Precision Medicine's Success

Researchers Sequence Genome of Anaplastic Large Cell Lymphoma

Researcher's resolve leads to breakthrough drug

Can cancer be stopped?

Dattatreyudu Nori awarded one of India's highest civil honors

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters